Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Holocene Advisors LP

Holocene Advisors LP decreased its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 20.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,906,723 shares of the company’s stock after selling 505,011 shares during the quarter. Holocene Advisors LP owned 1.12% of Option Care Health worth $59,680,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Westfield Capital Management Co. LP raised its holdings in Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after purchasing an additional 599,589 shares during the period. Harbor Capital Advisors Inc. raised its holdings in Option Care Health by 317.9% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock worth $2,670,000 after purchasing an additional 73,312 shares during the period. Global Alpha Capital Management Ltd. raised its holdings in Option Care Health by 108.3% in the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock worth $1,559,000 after purchasing an additional 25,905 shares during the period. Victory Capital Management Inc. raised its holdings in Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after purchasing an additional 1,585,818 shares during the period. Finally, Edgestream Partners L.P. raised its holdings in Option Care Health by 96.8% in the 2nd quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock worth $9,736,000 after purchasing an additional 172,845 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Performance

Shares of Option Care Health stock opened at $24.12 on Tuesday. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.63. The company has a market cap of $4.10 billion, a price-to-earnings ratio of 20.27, a PEG ratio of 2.46 and a beta of 1.33. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The business’s 50 day moving average price is $26.84 and its 200 day moving average price is $28.87.

Analyst Ratings Changes

A number of brokerages have commented on OPCH. Truist Financial reduced their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the company from $38.00 to $27.00 in a report on Monday, November 4th. Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and reduced their target price for the company from $38.00 to $26.00 in a report on Thursday, October 31st. Barrington Research reduced their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. Finally, Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $30.83.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction on Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.64% of the stock is owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.